Elu,
it's one of those questions that's hard to get an accurate number. If you look at peers, such as Imugene which is way ahead of us in development and has had one successful phase 1 trial. They peaked at 60c ps giving a mc of $4b. They have gone down a lot as all biotech minnows have. If we had a $4b mc that would equate to just under $2 ps! Imugene reached this with zero revenue. We need a confluence of many factors to work together for that to happen. A change in sentiment for biotechs, interest rates stabilising, and a successful phase 1 trial, some nice media articles and who knows. But it would be well north of 5c. PAB is still a very high risk play.
- Forums
- ASX - By Stock
- GENETAL
Elu, it's one of those questions that's hard to get an...
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.51M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $995 | 110.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 2842383 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 870467 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 2842383 | 0.008 |
17 | 4746715 | 0.007 |
11 | 2787680 | 0.006 |
8 | 3144992 | 0.005 |
5 | 4324000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 870467 | 3 |
0.010 | 1705082 | 4 |
0.011 | 1380000 | 4 |
0.012 | 372407 | 3 |
0.013 | 990000 | 2 |
Last trade - 11.40am 29/04/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |